SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-18-000125
Filing Date
2018-02-12
Accepted
2018-02-12 19:12:24
Documents
1
Period of Report
2018-02-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT onconova_fm4feb82018.html 4  
1 OWNERSHIP DOCUMENT onconova_fm4feb82018.xml 4 8384
  Complete submission text file 0000905718-18-000125.txt   10147
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022
Business Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022 212-446-2473
TYNDALL CAPITAL PARTNERS L P (Reporting) CIK: 0001219314 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 18598542